A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Clinical trial NCT03036150 · COMPLETED
Trial details
- NCT number
- NCT03036150
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-02
- Primary completion
- 2020-06-12
- Enrollment
- 4304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.